Literature DB >> 7505700

The regulation of neurofilament protein dynamics by phosphorylation: clues to neurofibrillary pathobiology.

R A Nixon1.   

Abstract

Neurofilament proteins are continuously modified during their lifetime by a succession of protein kinases and phosphatases. Site-specific phosphorylation or dephosphorylation within different polypeptide domains of each neurofilament subunit is now believed to regulate such behaviors of neurofilaments as subunit polymerization and exchange, axonal transport, interactions with other cytoskeletal proteins and degradation. Local regulation of phosphorylation events could account for variations in the size, morphology and dynamics of the neurofilament network in different regions of the neuron. The apparent greater plasticity of the neurofilament network in regions like the perikaryon, initial segment and nodes along the axon may provide some insight into the vulnerability of these regions in neurofibrillary disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7505700     DOI: 10.1111/j.1750-3639.1993.tb00723.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  27 in total

1.  Neurofilaments consist of distinct populations that can be distinguished by C-terminal phosphorylation, bundling, and axonal transport rate in growing axonal neurites.

Authors:  J T Yabe; T Chylinski; F S Wang; A Pimenta; S D Kattar; M D Linsley; W K Chan; T B Shea
Journal:  J Neurosci       Date:  2001-04-01       Impact factor: 6.167

Review 2.  Role of phosphorylation on the structural dynamics and function of types III and IV intermediate filaments.

Authors:  Ram K Sihag; Masaki Inagaki; Tomoya Yamaguchi; Thomas B Shea; Harish C Pant
Journal:  Exp Cell Res       Date:  2007-04-12       Impact factor: 3.905

Review 3.  Cerebrospinal fluid protein biomarkers for Alzheimer's disease.

Authors:  Kaj Blennow
Journal:  NeuroRx       Date:  2004-04

Review 4.  Probing modifications of the neuronal cytoskeleton.

Authors:  L C Doering
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

5.  Generalised nuclear and cytoplasmic inclusion disease: a rare case investigated by microscopy and immunohistochemistry.

Authors:  A Ruszkiewicz; K Opeskin; R M Anderson; C W Chow
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 6.  Cytoskeleton as a potential target in the neuropathology of maple syrup urine disease: insight from animal studies.

Authors:  R Pessoa-Pureur; M Wajner
Journal:  J Inherit Metab Dis       Date:  2007-06-14       Impact factor: 4.982

7.  Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's disease.

Authors:  Takahide Kaji; Barry Boland; Tatjana Odrljin; Panaiyur Mohan; Balapal S Basavarajappa; Corrinne Peterhoff; Anne Cataldo; Anna Rudnicki; Niranjana Amin; Bing Sheng Li; Harish C Pant; Basalingappa L Hungund; Ottavio Arancio; Ralph A Nixon
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

8.  Effect of propionic and methylmalonic acids on the in vitro phosphorylation of intermediate filaments from cerebral cortex of rats during development.

Authors:  Lúcia Maria Vieira de Almeida; Cláudia Funchal; Priscila de Lima Pelaez; Franciele Dall Bello Pessutto; Samanta Oliveira Loureiro; Lilian Vivian; Moacir Wajner; Regina Pessoa-Pureur
Journal:  Metab Brain Dis       Date:  2003-09       Impact factor: 3.584

9.  The Neurometabolic Cascade of Concussion.

Authors:  Christopher C. Giza; David A. Hovda
Journal:  J Athl Train       Date:  2001-09       Impact factor: 2.860

10.  Immunoblot analyses of the relative contributions of cysteine and aspartic proteases to neurofilament breakdown products following experimental brain injury in rats.

Authors:  R M Posmantur; X Zhao; A Kampfl; G L Clifton; R L Hayes
Journal:  Neurochem Res       Date:  1998-10       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.